Granulocyte Macrophage Colony Stimulating Factor Market

ID: MRFR/Pharma/4951-HCR
100 Pages
Rahul Gotadki
Last Updated: May 15, 2026
Granulocyte-Macrophage Colony-Stimulating Factor Market Research Report, by Route of Administration (Intravenous Infusion), Application (Fungal Infections, Cut-Burn Wounds), End-User (Hospital, Clinics, Surgical Centre) – Global Forecast Till 2035
Granulocyte Macrophage Colony Stimulating Factor Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.5%
2024 Market Size$ 0.24 Billion
2025 Market Size$ 0.26 Billion
2035 Market Size$ 0.49 Billion
Key Players
Amgen
Bristol-Myers Squibb
Novartis
Roche
Sanofi
Merck & Co.
Trends
  • Rising Demand for Immunotherapies
  • Advancements in Biotechnology
  • Collaborative Research Initiatives
Opportunities
  • Regulatory Support for Biologics
  • Rising Awareness of Immune Health
  • Increasing Prevalence of Chronic Diseases
Summary Table of Contents Segmentation Methodology Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Route of Administration (USD Billion)
      1. 4.1.1 Subcutaneous Bolus
      2. 4.1.2 Intravenous Infusion
    2. 4.2 Healthcare, BY Applications (USD Billion)
      1. 4.2.1 Fungal Infections
      2. 4.2.2 Skin-Graft
      3. 4.2.3 Cut-Burn Wounds
      4. 4.2.4 Acute Myelogenous Leukemia
      5. 4.2.5 Other
    3. 4.3 Healthcare, BY End-Users (USD Billion)
      1. 4.3.1 Hospitals and clinics
      2. 4.3.2 Surgical centers
      3. 4.3.3 Diagnostic centers
      4. 4.3.4 Research centers
      5. 4.3.5 Others
    4. 4.4 Healthcare, BY Region (USD Billion)
      1. 4.4.1 North America
        1. 4.4.1.1 US
        2. 4.4.1.2 Canada
      2. 4.4.2 Europe
        1. 4.4.2.1 Germany
        2. 4.4.2.2 UK
        3. 4.4.2.3 France
        4. 4.4.2.4 Russia
        5. 4.4.2.5 Italy
        6. 4.4.2.6 Spain
        7. 4.4.2.7 Rest of Europe
      3. 4.4.3 APAC
        1. 4.4.3.1 China
        2. 4.4.3.2 India
        3. 4.4.3.3 Japan
        4. 4.4.3.4 South Korea
        5. 4.4.3.5 Malaysia
        6. 4.4.3.6 Thailand
        7. 4.4.3.7 Indonesia
        8. 4.4.3.8 Rest of APAC
      4. 4.4.4 South America
        1. 4.4.4.1 Brazil
        2. 4.4.4.2 Mexico
        3. 4.4.4.3 Argentina
        4. 4.4.4.4 Rest of South America
      5. 4.4.5 MEA
        1. 4.4.5.1 GCC Countries
        2. 4.4.5.2 South Africa
        3. 4.4.5.3 Rest of MEA
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Amgen (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Bristol-Myers Squibb (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Novartis (CH)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Roche (CH)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Sanofi (FR)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Merck & Co. (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Eli Lilly and Company (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Pfizer (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 GSK (GB)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS
    3. 6.3 US MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    4. 6.4 US MARKET ANALYSIS BY APPLICATIONS
    5. 6.5 US MARKET ANALYSIS BY END-USERS
    6. 6.6 CANADA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    7. 6.7 CANADA MARKET ANALYSIS BY APPLICATIONS
    8. 6.8 CANADA MARKET ANALYSIS BY END-USERS
    9. 6.9 EUROPE MARKET ANALYSIS
    10. 6.10 GERMANY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    11. 6.11 GERMANY MARKET ANALYSIS BY APPLICATIONS
    12. 6.12 GERMANY MARKET ANALYSIS BY END-USERS
    13. 6.13 UK MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    14. 6.14 UK MARKET ANALYSIS BY APPLICATIONS
    15. 6.15 UK MARKET ANALYSIS BY END-USERS
    16. 6.16 FRANCE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    17. 6.17 FRANCE MARKET ANALYSIS BY APPLICATIONS
    18. 6.18 FRANCE MARKET ANALYSIS BY END-USERS
    19. 6.19 RUSSIA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    20. 6.20 RUSSIA MARKET ANALYSIS BY APPLICATIONS
    21. 6.21 RUSSIA MARKET ANALYSIS BY END-USERS
    22. 6.22 ITALY MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    23. 6.23 ITALY MARKET ANALYSIS BY APPLICATIONS
    24. 6.24 ITALY MARKET ANALYSIS BY END-USERS
    25. 6.25 SPAIN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    26. 6.26 SPAIN MARKET ANALYSIS BY APPLICATIONS
    27. 6.27 SPAIN MARKET ANALYSIS BY END-USERS
    28. 6.28 REST OF EUROPE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    29. 6.29 REST OF EUROPE MARKET ANALYSIS BY APPLICATIONS
    30. 6.30 REST OF EUROPE MARKET ANALYSIS BY END-USERS
    31. 6.31 APAC MARKET ANALYSIS
    32. 6.32 CHINA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    33. 6.33 CHINA MARKET ANALYSIS BY APPLICATIONS
    34. 6.34 CHINA MARKET ANALYSIS BY END-USERS
    35. 6.35 INDIA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    36. 6.36 INDIA MARKET ANALYSIS BY APPLICATIONS
    37. 6.37 INDIA MARKET ANALYSIS BY END-USERS
    38. 6.38 JAPAN MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    39. 6.39 JAPAN MARKET ANALYSIS BY APPLICATIONS
    40. 6.40 JAPAN MARKET ANALYSIS BY END-USERS
    41. 6.41 SOUTH KOREA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    42. 6.42 SOUTH KOREA MARKET ANALYSIS BY APPLICATIONS
    43. 6.43 SOUTH KOREA MARKET ANALYSIS BY END-USERS
    44. 6.44 MALAYSIA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    45. 6.45 MALAYSIA MARKET ANALYSIS BY APPLICATIONS
    46. 6.46 MALAYSIA MARKET ANALYSIS BY END-USERS
    47. 6.47 THAILAND MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    48. 6.48 THAILAND MARKET ANALYSIS BY APPLICATIONS
    49. 6.49 THAILAND MARKET ANALYSIS BY END-USERS
    50. 6.50 INDONESIA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    51. 6.51 INDONESIA MARKET ANALYSIS BY APPLICATIONS
    52. 6.52 INDONESIA MARKET ANALYSIS BY END-USERS
    53. 6.53 REST OF APAC MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    54. 6.54 REST OF APAC MARKET ANALYSIS BY APPLICATIONS
    55. 6.55 REST OF APAC MARKET ANALYSIS BY END-USERS
    56. 6.56 SOUTH AMERICA MARKET ANALYSIS
    57. 6.57 BRAZIL MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    58. 6.58 BRAZIL MARKET ANALYSIS BY APPLICATIONS
    59. 6.59 BRAZIL MARKET ANALYSIS BY END-USERS
    60. 6.60 MEXICO MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    61. 6.61 MEXICO MARKET ANALYSIS BY APPLICATIONS
    62. 6.62 MEXICO MARKET ANALYSIS BY END-USERS
    63. 6.63 ARGENTINA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    64. 6.64 ARGENTINA MARKET ANALYSIS BY APPLICATIONS
    65. 6.65 ARGENTINA MARKET ANALYSIS BY END-USERS
    66. 6.66 REST OF SOUTH AMERICA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    67. 6.67 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATIONS
    68. 6.68 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USERS
    69. 6.69 MEA MARKET ANALYSIS
    70. 6.70 GCC COUNTRIES MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    71. 6.71 GCC COUNTRIES MARKET ANALYSIS BY APPLICATIONS
    72. 6.72 GCC COUNTRIES MARKET ANALYSIS BY END-USERS
    73. 6.73 SOUTH AFRICA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    74. 6.74 SOUTH AFRICA MARKET ANALYSIS BY APPLICATIONS
    75. 6.75 SOUTH AFRICA MARKET ANALYSIS BY END-USERS
    76. 6.76 REST OF MEA MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    77. 6.77 REST OF MEA MARKET ANALYSIS BY APPLICATIONS
    78. 6.78 REST OF MEA MARKET ANALYSIS BY END-USERS
    79. 6.79 KEY BUYING CRITERIA OF HEALTHCARE
    80. 6.80 RESEARCH PROCESS OF MRFR
    81. 6.81 DRO ANALYSIS OF HEALTHCARE
    82. 6.82 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    83. 6.83 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    84. 6.84 SUPPLY / VALUE CHAIN: HEALTHCARE
    85. 6.85 HEALTHCARE, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
    86. 6.86 HEALTHCARE, BY ROUTE OF ADMINISTRATION, 2024 TO 2035 (USD Billion)
    87. 6.87 HEALTHCARE, BY APPLICATIONS, 2024 (% SHARE)
    88. 6.88 HEALTHCARE, BY APPLICATIONS, 2024 TO 2035 (USD Billion)
    89. 6.89 HEALTHCARE, BY END-USERS, 2024 (% SHARE)
    90. 6.90 HEALTHCARE, BY END-USERS, 2024 TO 2035 (USD Billion)
    91. 6.91 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.2.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.2.3 BY END-USERS, 2025-2035 (USD Billion)
    2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.3.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.3.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.3.3 BY END-USERS, 2025-2035 (USD Billion)
    3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
      1. 7.4.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.4.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.4.3 BY END-USERS, 2025-2035 (USD Billion)
    4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.5.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.5.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.5.3 BY END-USERS, 2025-2035 (USD Billion)
    5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
      1. 7.6.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.6.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.6.3 BY END-USERS, 2025-2035 (USD Billion)
    6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
      1. 7.7.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.7.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.7.3 BY END-USERS, 2025-2035 (USD Billion)
    7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.8.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.8.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.8.3 BY END-USERS, 2025-2035 (USD Billion)
    8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
      1. 7.9.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.9.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.9.3 BY END-USERS, 2025-2035 (USD Billion)
    9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.10.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.10.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.10.3 BY END-USERS, 2025-2035 (USD Billion)
    10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
      1. 7.11.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.11.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.11.3 BY END-USERS, 2025-2035 (USD Billion)
    11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. 7.12.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.12.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.12.3 BY END-USERS, 2025-2035 (USD Billion)
    12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.13.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.13.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.13.3 BY END-USERS, 2025-2035 (USD Billion)
    13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.14.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.14.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.14.3 BY END-USERS, 2025-2035 (USD Billion)
    14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
      1. 7.15.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.15.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.15.3 BY END-USERS, 2025-2035 (USD Billion)
    15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
      1. 7.16.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.16.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.16.3 BY END-USERS, 2025-2035 (USD Billion)
    16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
      1. 7.17.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.17.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.17.3 BY END-USERS, 2025-2035 (USD Billion)
    17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. 7.18.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.18.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.18.3 BY END-USERS, 2025-2035 (USD Billion)
    18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
      1. 7.19.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.19.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.19.3 BY END-USERS, 2025-2035 (USD Billion)
    19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. 7.20.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.20.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.20.3 BY END-USERS, 2025-2035 (USD Billion)
    20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.21.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.21.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.21.3 BY END-USERS, 2025-2035 (USD Billion)
    21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.22.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.22.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.22.3 BY END-USERS, 2025-2035 (USD Billion)
    22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
      1. 7.23.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.23.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.23.3 BY END-USERS, 2025-2035 (USD Billion)
    23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
      1. 7.24.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.24.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.24.3 BY END-USERS, 2025-2035 (USD Billion)
    24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
      1. 7.25.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.25.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.25.3 BY END-USERS, 2025-2035 (USD Billion)
    25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. 7.26.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.26.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.26.3 BY END-USERS, 2025-2035 (USD Billion)
    26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.27.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.27.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.27.3 BY END-USERS, 2025-2035 (USD Billion)
    27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. 7.28.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.28.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.28.3 BY END-USERS, 2025-2035 (USD Billion)
    28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
      1. 7.29.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.29.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.29.3 BY END-USERS, 2025-2035 (USD Billion)
    29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. 7.30.1 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Billion)
      2. 7.30.2 BY APPLICATIONS, 2025-2035 (USD Billion)
      3. 7.30.3 BY END-USERS, 2025-2035 (USD Billion)
    30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.31.1
    1. 7.32 ACQUISITION/PARTNERSHIP
  10. 7.32.1

Granulocyte Macrophage Colony Stimulating Factor Market Segmentation

Granulocyte Macrophage Colony Stimulating Factor Market By Route of Administration (USD Billion, 2025-2035)

  • Subcutaneous Bolus
  • Intravenous Infusion

Granulocyte Macrophage Colony Stimulating Factor Market By Applications (USD Billion, 2025-2035)

  • Fungal Infections
  • Skin-Graft
  • Cut-Burn Wounds
  • Acute Myelogenous Leukemia
  • Other

Granulocyte Macrophage Colony Stimulating Factor Market By End-Users (USD Billion, 2025-2035)

  • Hospitals and clinics
  • Surgical centers
  • Diagnostic centers
  • Research centers
  • Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.